National Institute for Health and Care Research (NIHR)

In a pioneering study funded by the UK Government, researchers at Imperial College London are set to examine the potential of psilocybin-assisted therapy to treat opioid addiction. As Leafie reported, this marks the first time that the UK government has backed research into using psilocybin for...

Biotech psychedelics company Awakn Life Sciences Corp. (OTCQB: AWKNF) has been granted funding for 66% of the costs from its phase 3 clinical trial  on ketamine therapy for alcohol use disorder (AUD) by U.K's National Institute for Health and Care Research. The trial is...